U.S. market Closed. Opens in 1 day 7 hours 42 minutes

ALLR | Allarity Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
RevenueN/AN/AN/AN/A120.00K1.46M1.46M143.28K362.29K9.97KN/A
Cost of Revenue37.00K120.00K106.00K86.00KN/A5.08M2.22MN/AN/A55.83K62.94K
Gross Profit-37.00K-120.00K-106.00K-86.00K120.00K-3.62M-761.50K143.28K362.29K-45.85K-62.94K
Operating Expenses17.89M16.89M26.56M9.23M10.24M1.36M3.08M4.63M1.76M22.81K18.24K
Selling, General & Admin10.03M9.96M12.36M4.10M3.87M1.28M3.07M272.39K89.15KN/AN/A
Research & Development7.87M6.93M14.20M5.13M6.37MN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/A-474.00K-681.00KN/A84.39K8.70K4.36M1.67M22.81K18.24K
Operating Income-17.93M-34.46M-26.56M-9.23M-17.61M-4.98M-3.84M-4.49M-1.40M-68.66K-81.19K
Other Expenses / Income5.31M-687.00K41.00K1.90M-8.86M1.53M-1.15M37.99K-130.58KN/AN/A
Before Tax Income-12.62M-17.58M-26.52M-7.23M-18.98M-3.46M-4.99M-4.45M-1.53M-68.66K-81.19K
Income Tax Expenses-717.00K-1.52M133.00K-2.16M-4.58M1.07M95.09K766.89K380.16KN/AN/A
Net Income-11.90M-16.06M-26.65M-5.07M-14.40M-2.29M-4.90M-3.68M-1.15M-68.66K-81.19K
Interest Expenses498.00K223.00K499.00K227.00K3.31MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding1.99B11.007.003.003.00N/AN/AN/AN/A1.17MN/A
Diluted Shares Outstanding1.99B11.007.003.003.00N/AN/AN/AN/A1.17MN/A
EBITDA-12.08M-17.24M-25.91M-6.01M-15.58M-4.90M-3.83M-4.21M-1.13M-45.85K0
EBITDA Margin0.00%0.00%0.00%0.00%-12,983.33%-335.42%-262.83%-2,937.94%-312.28%-459.71%0.00%
EBIT-12.12M-17.36M-26.02M-7.01M-15.66M-1.22M-4.80M-2.92M-766.81K-68.66K-81.19K
EBIT Margin0.00%0.00%0.00%0.00%-13,054.17%-83.70%-329.17%-2,035.11%-211.66%-688.39%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙